Literature DB >> 8112449

Thoracoscopy: present diagnostic and therapeutic indications.

R Loddenkemper1, C Boutin.   

Abstract

Thoracoscopy is increasingly being used for diagnosis and treatment of pleuropulmonary disease. The recent revival was made possible by the tremendous advances in endoscopic technology. The main requirements for diagnostic purposes are rigid telescopes and forceps, and for interventional thoracoscopy scissors, staplers and a video recorder. The procedure can be performed either under local or general anaesthesia, with or without double lumen intubation, after inducing an artificial pneumothorax. At the end of the procedure, a chest tube should always be inserted, even if only for a few minutes until the lung re-expands. Main diagnostic indications are pleural effusions, pneumothorax and diffuse lung disease. Main therapeutic indications are pleurodesis by talcage in effusion and pneumothorax and a variety of diseases of the lung, the pleura and the mediastinum, where thoracotomy may be replaced by video-assisted thoracoscopy. The well-known indications of the past remain a domain of pneumologists, whereas minimal invasive thoracotomy is the task of thoracic surgeons. For some indications no sharp line has to be drawn, provided the facilities and skills are present, including those for the management of complications.

Entities:  

Mesh:

Year:  1993        PMID: 8112449

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  17 in total

1.  Video assisted rigid thoracoscopy in the diagnosis of unexplained exudative pleural effusion.

Authors:  Samad Beheshtirouy; Farzad Kakaei; Mohammad Mirzaaghazadeh
Journal:  J Cardiovasc Thorac Res       Date:  2013-10-05

Review 2.  Malignant pleural effusions: appropriate treatment approaches.

Authors:  Yener Aydin; Atila Turkyilmaz; Yavuz Selim Intepe; Atilla Eroglu
Journal:  Eurasian J Med       Date:  2009-12

3.  Differential diagnosis of tuberculous and malignant pleural effusions: what is the role of adenosine deaminase?

Authors:  Bojan Zarić; Vesna Kuruc; Aleksandar Milovančev; Marica Markovic; Tatjana Šarčev; Vukašin Čanak; Slobodan Pavlović
Journal:  Lung       Date:  2008-03-21       Impact factor: 2.584

4.  Treatment of complicated parapneumonic pleural effusion and pleural parapneumonic empyema.

Authors:  Pedro Rodríguez Suárez; Jorge Freixinet Gilart; José María Hernández Pérez; Mohamed Hussein Serhal; Antonio López Artalejo
Journal:  Med Sci Monit       Date:  2012-07

5.  Developing a Prediction Score for the Diagnosis of Malignant Pleural Effusion: MPE Score.

Authors:  Chaichana Chantharakhit; Nantapa Sujaritvanichpong
Journal:  Asian Pac J Cancer Prev       Date:  2022-01-01

6.  Adequacy of pleural fluid cytology for comprehensive molecular analysis of lung adenocarcinoma: Experience of a large health-care system.

Authors:  Siddhartha Dilip Dalvi; Karen Chau; Sujata Sajjan; Baidarbhi Chakraborty; Priyanka Karam; Seema Khutti; Cecilia Gimenez; Kasturi Das
Journal:  Cytojournal       Date:  2022-02-04       Impact factor: 2.091

7.  Evaluation of pleural CYFRA 21-1 and carcinoembryonic antigen in the diagnosis of malignant pleural effusions.

Authors:  G Salama; M Miédougé; P Rouzaud; M A Mauduyt; M C Pujazon; C Vincent; P Carles; G Serre
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

8.  Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions.

Authors:  M Miédougé; P Rouzaud; G Salama; M C Pujazon; C Vincent; M A Mauduyt; J Reyre; P Carles; G Serre
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

9.  Closed pleural biopsy is still useful in the evaluation of malignant pleural effusion.

Authors:  Somnath Bhattacharya; Tapan D Bairagya; Anirban Das; Abhijit Mandal; Sibes K Das
Journal:  J Lab Physicians       Date:  2012-01

10.  Video-assisted thoracic surgery: applications and outcome.

Authors:  S Johna; A Alkoraishi; E Taylor; M Derrick; J H Bloch
Journal:  JSLS       Date:  1997 Jan-Mar       Impact factor: 2.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.